Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Disposal of unused meds
Exjade® (deferasirox) - product information

Exjade® (deferasirox)

Overview | Product information | Accredo services | Contact team


Exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. Exjade tablets are dissolved in water, orange juice, or apple juice, and the mixture is taken 30 minutes prior to consuming any food.1

For more information, please download the full prescribing information.


1. Exjade Prescribing Information. Novartis Pharmaceuticals Corporation


Exjade is a registered trademark of Novartis Pharmaceuticals Corporation.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us